▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3706 by analyst upside · 2026-09-27
ICLR
ICON Public Limited Company
Healthcare · Market Cap $13B · P/E 265.1x
ANALYST PRICE TARGET
+7.5%
implied upside to consensus target
Current Price $172.33
Consensus Target $185.25
Bull Target $220.0
Bear Target $155.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
8
Hold
6
Sell
1
52-Week Low $66.57
52-Week High $203.91
YTD Return -8.7%
FUNDAMENTALS
Market Cap $13B
P/E Ratio (TTM) 265.1x
Forward P/E 14.6x
EPS (TTM) $0.65
PEG Ratio 0.52
Dividend Yield N/A
Revenue (TTM) $8.3B
Profit Margin 0.3%
52-WEEK RANGE
52-Week Low $66.57
52-Week High $203.91
Current Price $172.33
Bear Target $155.0
Bull Target $220.0
● Now $172.33 ● Target $185.25
TRADING DATA
Avg Volume 805K
YTD Return -8.7%
Analyst Count 16
Consensus Buy
Upside to Target +7.5%
Last Updated 2026-09-27

ANALYST SUMMARY

ICON Public Limited Company (ICLR) is currently trading at $172.33 with a Wall Street consensus price target of $185.25, implying potential upside of 7.5% over the next 12 months. 16 analysts currently cover ICLR, with a consensus rating of Buy - 56% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $220.0, while the most cautious has a target of $155.0.

ICLR operates in the Healthcare sector with a market capitalisation of $13B. The stock is down 8.7% year-to-date and is currently trading near the upper end of its 52-week range of $66.57 – $203.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ICLR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Neutral → Neutral 2026-09-18 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-07-31 Building track record
Truist Securities reit
Buy → Buy 2026-07-31 Building track record
Truist Securities ↑ Upgrade
Hold → Buy 2026-06-30 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-06-26 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-06-25 Building track record
BMO Capital - Reiterated
Outperform → Outperform 2026-06-25 Building track record
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-06-25 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
22/30
Consensus clarity
22/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →